Brain MRI in Neurodegeneration with Brain Iron Accumulation with and without PANK2 Mutations

References

1. ↵
   Tanfani G, Mascalchi M, Dal Pozzo G, et al. MR imaging in a case of Hallervorden-Spatz disease. J Comput Assist Tomogr 1987;11:1057–58.

   CrossRefPubMedWeb of Science
2. ↵
   Sethi KD, Adams RJ, Loring DW, et al. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692–94

   CrossRefPubMedWeb of Science
3. ↵
   Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33–40

   CrossRefPubMedWeb of Science
4. ↵
   Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345–49

   CrossRefPubMedWeb of Science
5. ↵
   Hayflick SJ, Penzien JM, Michl W, et al. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:166–69

   CrossRefPubMed
6. ↵
   Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Z Ges Neurol Psychiatr 1922;79:254–302

   CrossRef
7. ↵
   Swaiman KF. Hallervorden-Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285–93

   CrossRefPubMedWeb of Science